KRAS and viral infectious disease: For example, the acetylation of NS3 inhibits RNA binding, but mutations in the virus that prevent NS3 acetylation inhibit viral infection [25], suggesting that the timing and reversibility of this modification may be an important regulator of NS3 function during infection.